Is Probiotics Antibiotic Associated Diarrhea Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Probiotics Antibiotic Associated Diarrhea Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Commentary: The effect of probiotics on the diarrhea and constipation outcomes in children: an umbrella review of systematic reviews and meta-analyses. [Peng Y (2026); evidence level 1] - Probiotics may strengthen gut barrier function and lower the risk of ventilator-associated pneumonia (VAP), but their effectiveness in mechanically ventilated patients remains unclear. [Jiang Y (2026); evidence level 2] - This umbrella review synthesizes evidence from systematic reviews on the association between probiotic therapy and VAP incidence. [Jiang Y (2026); evidence level 2] - Probiotic supplementation was associated with a reduced risk of VAP [odds ratio (OR) = 0.67, 95% confidence interval (CI): 0.61-0.75; relative risk (RR) = 0.74, 95% CI: 0.69-0.80] and nosocomial infections (OR = 0.81, 95% CI: 0.73-0.90; RR = 0.84, 95% CI: 0.80-0.88). [Jiang Y (2026); evidence level 2] - Background In critically ill patients, gut microbiome balance is often disrupted by antibiotics and disease-related stress. [Jiang Y (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.